DOACs to be analysed as part of genetic biobank scheme Patients who report adverse effects from direct oral anticoagulants to the Yellow Card scheme may be contacted to provide a blood sample, from which data will then be added to a biobank for researchers to analyse.…
More than £30m of illegal medicines seized by MHRA in 2023 The Medicines and Healthcare products Regulatory Agency says its support to online marketplaces led to the removal of more than half a million unregulated medicines and medical devices before they hit the UK market.…
MHRA says fluoroquinolones should be administered only when no other antibiotics are appropriate The Medicines and Healthcare products Regulatory Agency has issued new restrictions on fluoroquinolone use, following reports of serious adverse reactions in patients.…
Medicines regulator seeks expert advice on risk of developmental disorders in children fathered by men on valproate The Medicines and Healthcare products Regulatory Agency is to look again at evidence from a study evaluating the link between paternal valproate exposure and developmental disorders in children.…
FDA ‘evaluating regulatory action’ over link between GLP-1 receptor agonists and suicidal thoughts The US Food and Drug Administration said it had received reports of suicidal ideation in patients taking GLP-1 receptor agonists through its adverse events reporting system.…
Non-hormonal treatment for menopause vasomotor symptoms approved for use in the UK Fezolinetant is an alternative to hormone replacement therapy for people experiencing vasomotor symptoms of menopause.…
Smoking cessation medicine cytisine to be available in January 2024, distributor confirms Exclusive: Cytisine was approved for use in the UK by the Medicines and Healthcare products Regulatory Agency in March 2019, but no supplies have been previously available.…
Coroner advises NHS England to warn prescribers about interaction of tramadol and warfarin The coroner’s report says NHS England’s response “must contain details of action taken or proposed to be taken, setting out the timetable for action” or must explain why no action is proposed.…
MHRA will take a ‘more proactive approach’ to reclassification, says chief executive June Raine told delegates at an event held on 12 December 2023 that a 5% reduction in medicine prescribing through reclassification could save the NHS £1.4bn each year.…
New valproate prescriptions must be signed off by two specialist doctors from January 2024, says MHRA The requirement for valproate prescriptions, which will come into effect on 31 January 2024, was first announced in December 2022.…
